Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group - PubMed (original) (raw)
Multicenter Study
Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group
J Moye Jr et al. J Pediatr. 1996 Jan.
Abstract
Objective: To evaluate the nature and magnitude of the effect of congenitally or perinatally acquired human immunodeficiency virus (HIV) infection on somatic growth from birth through 18 months of age.
Study design: Anthropometry was performed serially in 282 term infants born to HIV-infected women in a multicenter prospective natural history cohort study. Repeated measures analysis was used to compare z-score anthropometric indexes of weight-for-age, length-for-age, weight-for-length, and head circumference-for-age between infected and uninfected infants, with adjustment for covariates including infant gender; maternal education; prenatal alcohol, tobacco, and/or illicit drug exposure; and mean prenatal CD4+ T-lymphocyte count. A separate repeated measures model was used to assess the effect of infant zidovudine treatment on growth.
Results: Infants infected with HIV were an estimated average 0.28 kg lighter and 1.64 cm shorter than uninfected infants at birth, were 0.71 kg lighter and 2.25 cm shorter by 18 months of age, and had a sustained estimated average decrement of 0.70 to 0.75 cm in head circumference. Patterns of growth were similar in male and female infants. Infected infants had a progressive decrement in body mass index from birth through 6 months of age. Infection with HIV was associated with significant decrements across all standardized growth outcome measures after adjustment for covariates. Mean z scores were lower for weight by 0.612 (p < 0.001), for length by 0.735 (p < 0.001), for weight-for-length by 0.255 (p = 0.02), and for head circumference by 0.563 (p < 0.001) SD units compared with uninfected infants. Zidovudine treatment was not associated with improved growth.
Conclusion: The effect of congenitally or perinatally acquired HIV infection on infant growth is one of early and progressive decrements in attained linear growth and growth in mass, early and sustained decrements in head growth, and marked early decrements in body mass index.
Similar articles
- Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.
Abrams EJ, Matheson PB, Thomas PA, Thea DM, Krasinski K, Lambert G, Shaffer N, Bamji M, Hutson D, Grimm K, et al. Abrams EJ, et al. Pediatrics. 1995 Sep;96(3 Pt 1):451-8. Pediatrics. 1995. PMID: 7651777 - Height, weight, and growth in children born to mothers with HIV-1 infection in Europe.
Newell ML, Borja MC, Peckham C; European Collaborative Study. Newell ML, et al. Pediatrics. 2003 Jan;111(1):e52-60. doi: 10.1542/peds.111.1.e52. Pediatrics. 2003. PMID: 12509595 - Growth of infants born to HIV-infected women in South Africa according to maternal and infant characteristics.
Venkatesh KK, Lurie MN, Triche EW, De Bruyn G, Harwell JI, McGarvey ST, Gray GE. Venkatesh KK, et al. Trop Med Int Health. 2010 Nov;15(11):1364-74. doi: 10.1111/j.1365-3156.2010.02634.x. Trop Med Int Health. 2010. PMID: 20955499 Clinical Trial. - Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS, Dokubo EK, Sint TT. Sturt AS, et al. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Cochrane Database Syst Rev. 2010. PMID: 20238370 Review. - Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Siegfried N, et al. Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Cochrane Database Syst Rev. 2011. PMID: 21735394 Review.
Cited by
- Growth patterns and their contributing factors among HIV-exposed uninfected infants.
Ndiaye A, Suneson K, Njuguna I, Ambler G, Hanke T, John-Stewart G, Jaoko W, Reilly M. Ndiaye A, et al. Matern Child Nutr. 2021 Apr;17(2):e13110. doi: 10.1111/mcn.13110. Epub 2020 Dec 2. Matern Child Nutr. 2021. PMID: 33269548 Free PMC article. - Impact of antiretroviral treatment on height evolution of HIV infected children.
Traisathit P, Urien S, Le Coeur S, Srirojana S, Akarathum N, Kanjanavanit S, Ngampiyaskul C, Krikajornkitti S, Ngo-Giang-Huong N, Lallemant M, Jourdain G. Traisathit P, et al. BMC Pediatr. 2019 Aug 17;19(1):287. doi: 10.1186/s12887-019-1663-8. BMC Pediatr. 2019. PMID: 31421667 Free PMC article. - Growth of HIV-Exposed Infants in Southwest China: A Comparative Study.
Chen JC, Zhang Y, Rongkavilit C, Wang B, Huang XM, Nong Z, Liu J, Zeng D, McGrath E. Chen JC, et al. Glob Pediatr Health. 2019 Jun 13;6:2333794X19854964. doi: 10.1177/2333794X19854964. eCollection 2019. Glob Pediatr Health. 2019. PMID: 31236432 Free PMC article. - Delayed tooth emergence in children infected with human immunodeficiency virus.
Psoter WJ, Nelson EM, Psoter KJ, Dearing BA, Katz RV, Catalanotto F. Psoter WJ, et al. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Oct;122(4):442-7. doi: 10.1016/j.oooo.2016.06.010. Epub 2016 Jun 29. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016. PMID: 27554377 Free PMC article. - Adverse bone health among children and adolescents growing up with HIV.
Sudjaritruk T, Puthanakit T. Sudjaritruk T, et al. J Virus Erad. 2015 Jul 1;1(3):159-67. J Virus Erad. 2015. PMID: 27482407 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials